Abstract

Abstract Breast tumors arise and progress via processes that involve intrinsic deregulation of epithelial cells and that also alter the composition and function of associated stromal and immune cells. Together, these tumor-intrinsic and microenvironmental changes enable malignant epithelial cells in the tumor to acquire key cancer hallmarks, including proliferation, migration, immune evasion and further evolution. The resulting collection of cancer and stromal cells comprise a complex, adaptive tumor ecosystem. Long-term therapeutic success will require that drugs attack malignant cells, favorably activate the immune system, and create a tumor microenvironment that does not support tumor (re)growth. Creating a process for treatment selection will require an integrated systems biology approach to develop, test and refine a robust computational framework that takes into account the states, signaling relationships, and spatial organization that determine the emergent properties inherent in complex interacting systems. Toward this goal, we have developed a coordinated experimental-computational approach designed to enable identification of effective treatment strategies. To examine therapeutic responses of diverse aspects of the tumor ecosystem, we have deployed a novel drug delivery microdevice that enables rapid, high-throughput assessment of the effects of multiple therapies on tumor cells and the surrounding microenvironment. When coupled with multiplex tissue imaging, this platform provides a comprehensive assessment of the state and spatial organization of the tumor ecosystem as it adapts to therapy. Initial studies demonstrated that many drugs designed to target malignant epithelial cells strongly impact stromal and immune cells, providing new insights into the importance of considering multiple aspects of the tumor ecosystem when designing effective therapeutic strategies. The resultant data are being used to guide development of a multiscale computational model that considers the functional relationships between different tumor components and can be used to predict the effects of therapies on diverse aspects of tumor ecosystems. In total, our approach has the potential to transform cancer treatments through rational identification of effective therapeutic strategies that lead to long-term durable control of tumors. Citation Format: Laura M. Heiser. Multiscale systems approach to target tumor ecosystem responses for therapeutic benefit [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Translating Cancer Evolution and Data Science: The Next Frontier; 2023 Dec 3-6; Boston, Massachusetts. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_2):Abstract nr IA019.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call